Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,864
Sort by:
2015 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals, Commercial Labs, POC Locations
US$ 27,600.00
... report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the Global Cancer Diagnostics ... , UK, USA WORLDWIDE MARKET OVERVIEW Five-year test volume and sales projections by country. Comprehensive market segmentation analysis, including review of the market dynamics, structure, size ...
June 2015
1200 pages
2015 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals, Commercial Labs, POC Locations
US$ 15,760.00
... available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the ... in Europe. Business Opportunities and Strategic Recommendations Specific new product development opportunities with potentially significant market ...
June 2015
820 pages
2015 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals, Commercial Labs and Physician Offices
US$ 5,360.00
... is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the ... in Germany. Business Opportunities and Strategic Recommendations Specific new product development opportunities with potentially significant market ...
June 2015
585 pages
2015 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals and Commercial Labs
US$ 5,360.00
... . The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the Spanish Cancer Diagnostics ... the rapid market expansion. Spanish Market Overview Five-year test volume and sales projections. Comprehensive market segmentation analysis, including review of the market dynamics, structure ...
June 2015
565 pages
2015 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals, Commercial Labs, POC Locations
US$ 7,840.00
... . The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. '2015 Market Segmentation Analysis of the US Cancer Diagnostics Industry ... and the rapid market expansion. US Market Overview Five-year test volume and sales projections. Comprehensive market segmentation analysis, including review of the market dynamics, structure ...
June 2015
620 pages
2015 New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape
US$ 27,800.00
... ) $21,100. '2015 New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape' is VPGMarketResearch's new study of the major business opportunities emerging in the global cancer diagnostics ... spectroscopy. Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic assessments ...
June 2015
1200 pages
Global Cancer Immunotherapy Market Outlook 2020
US$ 3,600.00
... Monoclonal Antibodies, Vaccines 'Global Cancer Immunotherapy Market Outlook 2020' Report Highlight: Introduction & Classification of Cancer Immunotherapy Global Cancer Immunotherapy Pipeline by Company, Indication & Phase Marketed Cancer Immunotherapies ...
June 2015
2600 pages
Cancer Immunomodulators Market & Pipeline Insight 2020
US$ 2,000.00
... Immunomodulators Cancer Immunomodulators Mechanism Cancer Immunomodulators Clinical Pipeline By Company, Indication & Phase Cancer Immunomodulators Clinical Pipeline: 747 Cancer Immunomodulators Drugs Majority Cancer Immunomodulators in Preclinical Phase: 300 Marketed Cancer Immunomodulators ...
June 2015
1000 pages
Global Cancer Biosimilars Market Opportunity Outlook
US$ 1,800.00
... Cancer Biosimilars Global Cancer Biosimilars Market Dynamics FDA & EMA Guidelines on Development & Marketing of Biosimilars Cancer Biosimilars Clinical Pipeline by Company, Indication & Phase Cancer Biosimilars Clinical Pipeline: 100 Biosimilars Marketed Cancer Biosimilars Clinical Insight Marketed Cancer ...
June 2015
550 pages
